Catalyst Wire Dossier Catalyst Wire Dossier

Avalyn Inhaled Antifibrotic Agent (SAIL)

· Avalyn Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Avalyn Inhaled Antifibrotic Agent (SAIL), covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) [Phase 2]

See pricing